Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 4
2018 3
2019 3
2020 5
2021 5
2022 8
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Th9 cells in allergic diseases: A role for the microbiota?
Badolati I, Sverremark-Ekström E, van der Heiden M. Badolati I, et al. Among authors: van der heiden m. Scand J Immunol. 2020 Apr;91(4):e12857. doi: 10.1111/sji.12857. Epub 2019 Dec 23. Scand J Immunol. 2020. PMID: 31811655 Free PMC article. Review.
Frailty is related to serum inflammageing markers: results from the VITAL study.
van Sleen Y, Shetty SA, van der Heiden M, Venema MCA, Gutiérrez-Melo N, Toonen EJM, van Beek J, Buisman AM, van Baarle D, Sauce D. van Sleen Y, et al. Among authors: van der heiden m. Immun Ageing. 2023 Nov 27;20(1):68. doi: 10.1186/s12979-023-00391-3. Immun Ageing. 2023. PMID: 38012652 Free PMC article.
Transcriptome changes during peanut oral immunotherapy and omalizumab treatment.
Björkander S, Merid SK, Brodin D, Brandström J, Fagerström-Billai F, van der Heiden M, Konradsen JR, Kabesch M, van Drunen CM, Golebski K, Maitland-van der Zee AH, Potočnik U, Vijverberg SJH, Nopp A, Nilsson C, Melén E. Björkander S, et al. Among authors: van der heiden m. Pediatr Allergy Immunol. 2022 Jan;33(1):e13682. doi: 10.1111/pai.13682. Epub 2021 Oct 31. Pediatr Allergy Immunol. 2022. PMID: 34669990 No abstract available.
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.
Malahe SRK, Hartog YD, Rietdijk WJR, van Baarle D, de Kuiper R, Reijerkerk D, Ras AM, Geers D, Diavatopoulos DA, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Bemelman FJ, Gansevoort RT, Hilbrands LB, Sanders JS, GeurtsvanKessel CH, Kho MML, de Vries RD, Reinders MEJ, Baan CC; RECOVAC Consortium RECOVAC collaborators. Malahe SRK, et al. Am J Transplant. 2023 Sep;23(9):1411-1424. doi: 10.1016/j.ajt.2023.05.025. Epub 2023 Jun 1. Am J Transplant. 2023. PMID: 37270109 Free PMC article.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Kho MML, Messchendorp AL, Frölke SC, Imhof C, Koomen VJ, Malahe SRK, Vart P, Geers D, de Vries RD, GeurtsvanKessel CH, Baan CC, van der Molen RG, Diavatopoulos DA, Remmerswaal EBM, van Baarle D, van Binnendijk R, den Hartog G, de Vries APJ, Gansevoort RT, Bemelman FJ, Reinders MEJ, Sanders JF, Hilbrands LB; RECOVAC collaborators. Kho MML, et al. Lancet Infect Dis. 2023 Mar;23(3):307-319. doi: 10.1016/S1473-3099(22)00650-8. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354032 Free PMC article. Clinical Trial.
Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial.
Vinke JSJ, Altulea DHA, Eisenga MF, Jagersma RL, Niekolaas TM, van Baarle D, Heiden MV, Steenhuis M, Rispens T, Abdulahad WH, Sanders JF, De Borst MH. Vinke JSJ, et al. Among authors: heiden mv. Front Immunol. 2023 Jan 4;13:1017178. doi: 10.3389/fimmu.2022.1017178. eCollection 2022. Front Immunol. 2023. PMID: 36618359 Free PMC article. Clinical Trial.
27 results